Form
Fill Out The Form To Begin Your Download
Curapath and Certest have teamed up to develop next-generation Lipid Nanoparticle (LNP) formulations for nucleic acid-based therapeutics. This novel formulation combines Curapath's PEG-alternative shielding lipid with Certest's enhanced ionizable lipid, addressing challenges like immune-related side effects and reduced efficacy of PEG-based systems. This collaboration aims to improve stability, efficiency, and the versatility of payload delivery in advanced therapies.. Learn more about this cutting-edge combination of technologies by accessing the full document..
Support for Your Therapeutic Program
Contact a Chemist Today
Contact Us, and we can discuss your specific therapeutic program and how Curapath can help build the right solution to advance your unique drug.